Cefdinir Powder, For Suspension
Product Images NDC 63187-835

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 63187-835). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

63187-835-00 (Cefdinir Fig1)

This is a description for Cefdinir, an oral suspension medication with a dosage of 125mg/5mL, manufactured by Aurobindo Pharma Limited in Hyderabad, India. The product is packaged in a 100 mL bottle with an expiration date of 00/00/00 and an NDC number of 63187-835-00. The suspension must be reconstituted before use, and each 5 mL contains 125mg of cefdinir USP. Storage conditions are specified to be between 20°-25°C (68°-77°F), and the medication should be kept out of reach of children.*

FDA Label Image

Chemical Structure (Cefdinir Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.